Google TrendNOVIG (2000+) — Novig Sign Up Bonus: ROTOWIRE Gets $50 in Trade Credits
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Early Data Show Promising" (30 stories)

Top Headline Story

New literacy data shows promising gains for North Carolina students
Lead StoryEdNCtech
Oct 2

New literacy data shows promising gains for North Carolina students

<a href="https://news.google.com/rss/articles/CBMikwFBVV95cUxPNTNmMzhKUURUU0JhV1NFOGhpRmx2UzFoLWpvM0ZWQXdCZGRjdFRVQmtmVDU4LW5TZXVOMGhlNmxlUjNXWlY2WFkyeTJTdGluS0VuM2tFa3R5WE5Lb3ZSR21VeHEtMmZjdW9adGpPaHZXRlEwZU9HcUd6TjlMSmx5MDlPZkI1ZHA3ei1rZ0NiN295cjg?oc=5" target="_blank">New literacy data shows promising gains for North Carolina students</a>  <font color="#6f6f6f">EdNC</font>

Real-time search volume
2000+19m ago

novig

Novig Sign Up Bonus: ROTOWIRE Gets $50 in Trade Credits

500+19m ago

boise state vs fresno state

Boise State gets big health boost, but injury concerns remain vs. Fresno State

500+19m ago

sounders

NEvsSEA Starting XI: Dejan Joveljić and Yeimar return to starting lineup, Sebastian Gomez gets the nod

200+19m ago

pedro pascal

Pedro Pascal in ‘Behemoth!’: The Oscar-Worthy Role That He (and Latinos) Have Been Waiting For

Search Results for "Early Data Show Promising"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Phase 1 Data Show Early Promise for SYNC-T Therapy SV-102 in Refractory Prostate Cancer; Phase 2 LEGION-100 Trial Ongoing
OncLivegeneral

Phase 1 Data Show Early Promise for SYNC-T Therapy SV-102 in Refractory Prostate Cancer; Phase 2 LEGION-100 Trial Ongoing

<a href="https://news.google.com/rss/articles/CBMi0wFBVV95cUxQVGN3UXJTSkhoSkNVLUlGblBJcXBpRjRVOUFveE1pbFdJYkhMMjR6THJ3NmJ6OGIxczJWLWRUdTJzenpHZGxVTUVRRWFSUmREMnFjeUgtX1h2VWdzYUJSRXJLQUFHcEFrV2dWTGhFVXdDYnJ1ZG5jdnZHUjhmLW9ENkdHUWF3bmgwbTVOSDhKa21NVVVRS2pmb1RtcG9maWxkVzBXUG9tSXVZM0F2aWphSU55aEhJdy1hMnlxTnlLcnFNeDUzb0syTHp2aTFFNGxuX05R?oc=5" target="_blank">Phase 1 Data Show Early Promise for SYNC-T Therapy SV-102 in Refractory Prostate Cancer; Phase 2 LEGION-100 Trial Ongoing</a>  <font color="#6f6f6f">OncLive</font>

Cancer vaccine from Moderna, Merck shows promise in late-stage trial; both stocks soar
CNBCmarkets

Cancer vaccine from Moderna, Merck shows promise in late-stage trial; both stocks soar

<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxOUlktR2pLY0JiWFdHWWtNb2ozX2ltdUZPV0F3SlNud0o5aUF0Nk16bEZjTU9yWW1sd044bnlwYWxrM0pGaDE5TGRQS2hlWGNtbVJIOF8zNVpQOWF5S1FMUXdCeV85Y1oxOG9Dck9ydjZGcGN2czgxOE5aeFY5Y3BVVExITTZpY1JUbG9sMHYtZmpCRzZGa1dGNUJBR0JvTl9TRmZ6R0NxSdIBrAFBVV95cUxNSDhhdThuTXRTbkNHRzIzVklfb3M0S1pjWWFSNTBhal9GQlVWZzBZVkpDeEVlREc2eEYyNTRNSkdvSzZ3cVBQanc3S012LWZocFVoTXJNMHVJaHFNSFBlZG1vMFZ3eTk0NzhSUEdXSGR4QXY5N1o5Q1FPN3czNTFHOURrektERU02MFQxRmMtTDJrNFhDeEE5OHBFVHBHRzRCeGZZNjBjV3BNZmVY?oc=5" target="_blank">Cancer vaccine from Moderna, Merck shows promise in late-stage trial; both stocks soar</a>  <font color="#6f6f6f">CNBC</font>

Early Data Look Promising for Nickel-Free Siegel TAVI Valve
TCTMD.comgeneral

Early Data Look Promising for Nickel-Free Siegel TAVI Valve

<a href="https://news.google.com/rss/articles/CBMiigFBVV95cUxNTUdCbUd2S0Z1bUNRcldPQW1FM2puY2hsZTR6a1Y2VGVELUUtSEFDUEhSbTJMZER1NWtYZW16ZzY0Q21GTHhxdWlwQnRWUWlXaGk1dFdaSHBGZTBzSXpsV1BETVJmMkdhSnM2SVRsbWRzMndud2ZQU2hTUzk5Q2EtSThjcFhTZ0djSEE?oc=5" target="_blank">Early Data Look Promising for Nickel-Free Siegel TAVI Valve</a>  <font color="#6f6f6f">TCTMD.com</font>

Enliven Therapeutics’ leukemia drug shows promise in new study
STATgeneral

Enliven Therapeutics’ leukemia drug shows promise in new study

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxQZDl6dzZ5bmE0SVBUWDRsZ2hTbEttZ2VXQU82bWtzQTVEUGpTQ1poWXdLejJaTFBPaU56Qm9FdGZWYWFlY09MaTJnYmRWekdHVVZnSnp1UHBCVE54T3NyeVA2M1dhSjdTZUloSjBtc01NQjRJWmpONVVYenpOUDlaR1VjOEFaZkhSSWZWdGdn?oc=5" target="_blank">Enliven Therapeutics’ leukemia drug shows promise in new study</a>  <font color="#6f6f6f">STAT</font>

Targeting APOE4: A Promising Therapeutic Strategy for Alzheimer Disease
Psychiatric Timesgeneral

Targeting APOE4: A Promising Therapeutic Strategy for Alzheimer Disease

<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxNQ05VZjU1ZG16aGNqUEgxNWtxUTBpTjhGT2Z0LU01X0xYMjJpMzlIaXdpR0ZkUjJac2l3R3dEM1pPMzJ6NldnZTA0SEtXVGdpclZaTkxUaDQxcVVsSlZpVjFQeUxqQzRiOXJ1Ujc1Y3lQVEFHeHZZbVBqUlcwaGpQVXROX3RQQV9IMWlVZkRFbktjMkhZemkzWnphcmwyOFQwVGdPaUptc0hxeklZ?oc=5" target="_blank">Targeting APOE4: A Promising Therapeutic Strategy for Alzheimer Disease</a>  <font color="#6f6f6f">Psychiatric Times</font>

Tango Therapeutics: Promising Early Data, But A Long Road Ahead
Seeking Alphageneral

Tango Therapeutics: Promising Early Data, But A Long Road Ahead

<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxNSDd5MHR5cDhBSlMwekFlc3o5WDFEM3BvTkk1S05hcDlqSUpUTnNpbkdlU0pCWkExa0Q5bEluZ1I1bTFuVC1hLThVSkhIZkNUd0FnR05zbHJiRnB6cG1yWnVnMjhheHpmUmhIVkJyN21hSmdxNW5FWWVHVmdQbUdnNEQ3SlhvbTBJdlNOVTdjV2FzSTF0VFpjVE5fOU16RWxsNERWNw?oc=5" target="_blank">Tango Therapeutics: Promising Early Data, But A Long Road Ahead</a>  <font color="#6f6f6f">Seeking Alpha</font>

Early Data Show Promising Outcomes as CAR T-Cell Therapy Expands Beyond Academic Centers
AJMCgeneral

Early Data Show Promising Outcomes as CAR T-Cell Therapy Expands Beyond Academic Centers

<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxPUmFVTC1CZHoyU1JZSmhSQmFPZXVmaFZsMkFjSWZqQ3JjNVM1OS1rV01xdFZ2UW55ZkhDMlNZZ3Q3N09mSlF5UGJGZEY3TlpaaWtWcGV5UHh6cHpKTWNhOFR4a0h0OGFwU3ZGZk1jY3Z5WDlvaVVnM0NvcW1oRWNfUll0R2V1V0wyMEdhVnR0dUkwcUVabktock1JazFvN1ZtOXMxVFhhOVpSVGEyRWlYdFB5a2Q?oc=5" target="_blank">Early Data Show Promising Outcomes as CAR T-Cell Therapy Expands Beyond Academic Centers</a>  <font color="#6f6f6f">AJMC</font>

Trump’s Promises of a US Manufacturing Revival Fell Flat, First-Half Data Shows
WWDgeneral

Trump’s Promises of a US Manufacturing Revival Fell Flat, First-Half Data Shows

<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxNUmJ5VEVkTHlVb1NMaUlNQ1E5QU80UnFOc1ZiMGNVZi15M0xQbXZwSDU2MElEWEZzSmNWbFhObXhVeFhkMjhjcVYtQ2VDWkx2ZmRsQ2lXU3g2SFRmdGhzdGJXYzgzQ0tuMlZFNUszaEZndGgtTW9DWHNpQXpreUpscEFmRmpFc3lZYVBVS0JsWnJxR1BBTGMzejNPcXVZcjNRc0hVaVozNFhEazAzNWxGel83ZW16OUdJ?oc=5" target="_blank">Trump’s Promises of a US Manufacturing Revival Fell Flat, First-Half Data Shows</a>  <font color="#6f6f6f">WWD</font>

Nicotine pouches promised to help American smokers quit. So far, the evidence for that is limited
The Examinationgeneral

Nicotine pouches promised to help American smokers quit. So far, the evidence for that is limited

<a href="https://news.google.com/rss/articles/CBMif0FVX3lxTE9wMEtqbkl2eldnWTVmcUl6MDgzaUstSDJnUG9uMXhxNkp2REhPZGFxUTBaNVNwcWxGSzlidzNjcXFGRkZWS3hQYUIxeFdBVHpxcUxWY0RsdGZaLVI4SG8tMzdVYy1aOVp0NElDcDBZd3NoSkVtaWItZFJrbDVYZEE?oc=5" target="_blank">Nicotine pouches promised to help American smokers quit. So far, the evidence for that is limited</a>  <font color="#6f6f6f">The Examination</font>

Expert: Early Phase 1 Data Show KTX-1001 Targeting NSD2 Offers Promise for Relapsed/Refractory Multiple Myeloma
Pharmacy Timesgeneral

Expert: Early Phase 1 Data Show KTX-1001 Targeting NSD2 Offers Promise for Relapsed/Refractory Multiple Myeloma

<a href="https://news.google.com/rss/articles/CBMi3wFBVV95cUxOR2g1aFBJN2E0alN4Y0hXV0ZLRVFpZ2stVVRyQVBadGRpTDFPeWVNWU5pb1AzekpzTXVzOExXTU9LZENBbUJmQzR1MkxiX19pd1h5WEQtYzQ1b0lkNl9MMXBhUkw5cU5adXRaaW9UNzJocXdxR296eVVQWEN6ME1YalFKV01RUWY4T2VuOGRabzA2UXpVX2dYTUlQekFTT1FIVmMzUjNaU1VjTkpoTGZtdHhXYUdFZmRBRERjTlpIX3YteEM0dEdBOC1LVGQ3Sm44TTNJamNsOVd0SVVtR0Yw?oc=5" target="_blank">Expert: Early Phase 1 Data Show KTX-1001 Targeting NSD2 Offers Promise for Relapsed/Refractory Multiple Myeloma</a>  <font color="#6f6f6f">Pharmacy Times</font>

Autologous Stem Cell Approach Shows Promising Early Phase 1 Data in Alzheimer Disease
NeurologyLivegeneral

Autologous Stem Cell Approach Shows Promising Early Phase 1 Data in Alzheimer Disease

<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxPRjBLWnJXMEwtbDhTWU5sbnVlVEdTY0h4eUFkdDN6b0Fzc1JpYloxRDlxYjFwU3p6YjRaZzlDMlFHNFQwWnd3dzlJRkczVmkyQi1jUEZCbzB3Ul9zcUVITWNKWXR6aXBLMjZYVlF5M0gwQUZMLV9NOEZnb2ZwSXdaQ1R5RWo1VzNpejVvdXZGXzVGNjlWVlROZm05a0xwUFR1dXFBdHFn?oc=5" target="_blank">Autologous Stem Cell Approach Shows Promising Early Phase 1 Data in Alzheimer Disease</a>  <font color="#6f6f6f">NeurologyLive</font>

Dravet syndrome gene therapy shows promising early data in trial
Dravet Syndrome Newsgeneral

Dravet syndrome gene therapy shows promising early data in trial

<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxOaHNpdmZpYjFjbm5sazFEWk5EZVVDTS1JWjEtcHlPSTkyU3g4LXR3dGdlSTA0d2JLRTJpRjNkbENFdmhUOFE4bXVFUkV3SXBMWV9oUEVXS3N2dVBUczg5bWplRGRXYXo1d2NGVHJISzFqWkZYV3BUMlVyOHhxYTU0YV85aXFDbDVtWVdhRE1MRWRkTlVEazRhZ1JTX1J0Rnc?oc=5" target="_blank">Dravet syndrome gene therapy shows promising early data in trial</a>  <font color="#6f6f6f">Dravet Syndrome News</font>

Early 2024 Data Show Promising Signs of Another Historic Decline in Gun Violence
Center for American Progressworld

Early 2024 Data Show Promising Signs of Another Historic Decline in Gun Violence

<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxQc3dGT2JLdWlfSmJHQ2ZuQmhLYVRpVm1DY1N4QmVTVE45T0s3Vzl2aEE2LVpfY1E4RW5PdVJiUk55MDFOVF9kdkNOU3dPMWZldjVGZENhZlVJME96RFg2THdMNlpqQ2hkdk1nU2JWdndRNGQzSldfclVSaVRKNnBGTkVNOWdPd3JmZ18zbFpnZVlMdjVqejZqNG0tYlZWYmNGWFBEY1FrRk1OOXd2OU1tenp0bWdEVGdORlVqeU5FZw?oc=5" target="_blank">Early 2024 Data Show Promising Signs of Another Historic Decline in Gun Violence</a>  <font color="#6f6f6f">Center for American Progress</font>

Early Data of LEU011 Show Encouraging Potential in Solid Tumors
Targeted Oncologygeneral

Early Data of LEU011 Show Encouraging Potential in Solid Tumors

<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxPeXlBNXRHT1cwQWUzbC0zeVF4TjdkSWdnaGs5STVzWmc0RFkxVzlZMXpHSzg1bjBJTTRSOXVPS0l1WXZ0Q25PYVp6ODlTWTZQR2NnTFJxZ0EzRlUtWVlSaWpMbjdrcmJhblljbC1wRzdOWEFmaXZYMXU1Q2pKemNxY3U1STNpRmdJZDBrZkt6MFA1RkxLS1lhSlpBRTE?oc=5" target="_blank">Early Data of LEU011 Show Encouraging Potential in Solid Tumors</a>  <font color="#6f6f6f">Targeted Oncology</font>

Myelin Protective Small Molecule Lucid-MS Shows Promising Early-Stage Data in Healthy Volunteers
NeurologyLivescience

Myelin Protective Small Molecule Lucid-MS Shows Promising Early-Stage Data in Healthy Volunteers

<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxNNFNTcHJkYWxhUE5KRHUxajl3SFFSQ0dZRXc5RTZ6Z3JmeWZUOEl6dzMtaW9CWTdud1lHQlFaNEdUbXFRODhSZDVNa3MtZGkwa3VjSFF2a1M2Ml85NHpkSzc2aTl5aTZOcEhlbElhMU9lZGZ4c0N1YzlJbVcyeGFCRFFVdUh3V3lMRVB6Q3lqY0NHUVlrNTJVdTVZSTQydVJQdWNETHRaVTJDYzRfWHdBZlpBbVVDTFNjVEdBQVpTbw?oc=5" target="_blank">Myelin Protective Small Molecule Lucid-MS Shows Promising Early-Stage Data in Healthy Volunteers</a>  <font color="#6f6f6f">NeurologyLive</font>

Early ASP2138 Data Show Encouraging Activity and Improved Safety in Gastric, GEJ Cancer
Pharmacy Timesgeneral

Early ASP2138 Data Show Encouraging Activity and Improved Safety in Gastric, GEJ Cancer

<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxPRko4MlphdWNJdmh3QmtUZy1RaWw1Y2VuQlkzajg2R0tiNUQzd0xmRXBmSWhCUWZ4N0o1X01RVXMtdkxzMDdtem1ob2JoaGxPdllLTktYY0FCQkJ0cHVZdUl3dnVMRkZNeDNtaVVENUdlZDI1dU9RaVpNVWgwRVEzVFFHSU9UM0JjaEZJOW9GUnBLT1lCQWEydVdVMGhEYzBQRHJ2U0IxRzd6bDVibmRfelBwY2ZUX1hLY3VQN2Vn?oc=5" target="_blank">Early ASP2138 Data Show Encouraging Activity and Improved Safety in Gastric, GEJ Cancer</a>  <font color="#6f6f6f">Pharmacy Times</font>

In Vivo CAR T Takes Center Stage, With Results Shared for 4 MRD-Negative Patients
AJMCgeneral

In Vivo CAR T Takes Center Stage, With Results Shared for 4 MRD-Negative Patients

<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxQX0ZUVlN3RXl2eTZfbXNKMnd6Ml9Ra1k4Mk1BOTZmWkdMN0x2UHVWTFpWNVFudGpOMW9lUWJIYVBDdUxiX055RlpuUnVrZkZsdG5BbUJpbW91UFVyWmgyX1pNVTRWcUt0UWZ6OW5DeDd6ZUItVWNiaDFOS3M0ZGt4Q3V3SV9wWEhlVm9DakNsZVdGNzk2aVFZQXZLM1J5YWFkY041NGhGODNaZw?oc=5" target="_blank">In Vivo CAR T Takes Center Stage, With Results Shared for 4 MRD-Negative Patients</a>  <font color="#6f6f6f">AJMC</font>

Talquetamab/Cetrelimab Leads to Deep, Durable Responses in R/R Multiple Myeloma
OncLivegeneral

Talquetamab/Cetrelimab Leads to Deep, Durable Responses in R/R Multiple Myeloma

<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxPNFZTZmhieWNHVVFzVm92UmkyX3RpaUZhLTZVX0RwYjhTX0hIUkZucHc1WElKRHZjS0ZfUWs3TEQ3aDBXaGtRdkxISzhraEJRVGdNOVpIQWhSLVJSTkI1Sm55U0M4ZEVjdThWR2J0aWlyVk9tQkNuMXVUUUZEN0g4TXgxX1BXa1VoZGgtcWpXN0RvdHlEYUlRYzMxX21fSV9MN2xWVjlfU3gtMWM?oc=5" target="_blank">Talquetamab/Cetrelimab Leads to Deep, Durable Responses in R/R Multiple Myeloma</a>  <font color="#6f6f6f">OncLive</font>

Orexin Agents ORX750 and ORX142 Show Promising Early Phase 1 and 2 Data
NeurologyLivegeneral

Orexin Agents ORX750 and ORX142 Show Promising Early Phase 1 and 2 Data

<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxONU5OamRtcGxnNzlidWFvdzBlb3BpVWl3OXo0WDBrTkpMdGdvVENKaHZUdUtXaHQxVHlUZDc5M0dhYmRmUlAxc1lBYUk2dFp5NTRsT1E2dEdScXY4YnloSU5kLTNEZVMzdUtrNEF2NGI4WmhFN0VBZlIxRTQ0TXdqdm4tU3NpX2ZYYTFJVnlkTU9zVzlnOHQ2RnRXQm5WckE?oc=5" target="_blank">Orexin Agents ORX750 and ORX142 Show Promising Early Phase 1 and 2 Data</a>  <font color="#6f6f6f">NeurologyLive</font>

Anti-HIV CAR-T Cell Therapy Shows Promise in Phase 1/2a Data
Contagion Livegeneral

Anti-HIV CAR-T Cell Therapy Shows Promise in Phase 1/2a Data

<a href="https://news.google.com/rss/articles/CBMihAFBVV95cUxQRk9heHhKeXZFRVdLM2N1WHRCVS16a3dWTlBKV3Z1a2ZDNGhuR2pfQkpOVnlWMUYwMHU3NnN6ZnJ6dlQzUUFqMWdYanFUWHVGUzByZ3lycnplZy05YXFOY2k2Ri1wZzFRa3o0WmtFdDFiM1VjZFh0Zmw3MzBDcjhzLVlnTU8?oc=5" target="_blank">Anti-HIV CAR-T Cell Therapy Shows Promise in Phase 1/2a Data</a>  <font color="#6f6f6f">Contagion Live</font>

Subcutaneous Cevostamab Shows Early Promise in R/R Myeloma
Targeted Oncologygeneral

Subcutaneous Cevostamab Shows Early Promise in R/R Myeloma

<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxPNnR2UHhrZkhlalMxWG44UDlnejVETVFFQ1hRUDBGTXpqOEFSbHFEUUp0RU9xcWxGNUpSS0VIajVVT0c3YXJFa1dHUFVxVlY1aU92LVNKcEFsVmZaamNUMDZac1o5bzhSY2w0NzF2OTlSc1dPczVRbV9IYUxXa2VPQzM4dFpLSEh6WWxzY0ludnBNaFpLVFE?oc=5" target="_blank">Subcutaneous Cevostamab Shows Early Promise in R/R Myeloma</a>  <font color="#6f6f6f">Targeted Oncology</font>

Novel ADC Combo Shows Efficacy in Phase 2 Bladder Cancer Data
Oncology News Centralgeneral

Novel ADC Combo Shows Efficacy in Phase 2 Bladder Cancer Data

<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxNNDBPN0lzaUkyVnV5S2Q5Z3M0eEVTRGc2SDEzemxPNFVzMzRucXRPdVNtN0Y2ZGJqWGVtMDd4WjNyME4xMU1qQ0VDdkNIZEVCWUUxZV94OWEzdno1REtrVzlpMU41VUJQMndyZXpsV04yUTBBUEVfY0Uyc3BGYnJWQU1YandiNGpkX0x0dkZKZ3k5emp5dGFEQ2h4Q1JTMm5QNG52aG15U0VHd3h0cjlCZlRR?oc=5" target="_blank">Novel ADC Combo Shows Efficacy in Phase 2 Bladder Cancer Data</a>  <font color="#6f6f6f">Oncology News Central</font>

Parkinson’s treatment tested at UW showing promise in first clinical trial
UW–Madison Newsgeneral

Parkinson’s treatment tested at UW showing promise in first clinical trial

<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxPbTNYSmYxN2ZiRUZXZWVacUVpamhHRFpDTFM5akU4dWhZaF8zck9QS2ZPZndVVFBoNl9Kek5yd0JJNHF2RlFYWERyeHZvMnEzbFJJYnlQX001MnBFejZsMnNUZGZOLVNUaGx1RGNkMVBfdTdEOUtrUFJVWE14QTByOWUyb3dTMG5icGtVWEdIS043a3YxQXBFRnR4VzE?oc=5" target="_blank">Parkinson’s treatment tested at UW showing promise in first clinical trial</a>  <font color="#6f6f6f">UW–Madison News</font>

ASH25: Kelonia touts promising early-stage data for in vivo CAR-T therapy in myeloma
FirstWord PHARMAgeneral

ASH25: Kelonia touts promising early-stage data for in vivo CAR-T therapy in myeloma

<a href="https://news.google.com/rss/articles/CBMiU0FVX3lxTE0yZ2JMeDh5X0Z4cVhpUnY4aEdZSzlqQlRQVUpObmFfZFdTcUVwcDZjalQtRW51ZnRTbWhVN1JXNnAtM2RfSWJXU3VDTVJ1Rzd5b204?oc=5" target="_blank">ASH25: Kelonia touts promising early-stage data for in vivo CAR-T therapy in myeloma</a>  <font color="#6f6f6f">FirstWord PHARMA</font>

Early Trial Data Show Promising Results for GM-CSF Blockade in CMML
Hematology Advisorgeneral

Early Trial Data Show Promising Results for GM-CSF Blockade in CMML

<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxQMVdyWWpYM05STTI5cUNfc0FSb29CR1I0RnE3N2JqWWFlRWpmOXlnSmdsQWZsTzI1TTRLVFp4SnlDM1oySXlEcHNFWUx5YzN1UVRvNHU0MWR2N3pRRi1Bb3Z4R1g4LU93RzJwdlpEWk41T1hNM3NVb2UtSnBxNjliOU9HR0dLaE1CWWE2TDFuS3ZSN0phVkg4WHZPdHdQdW45R1BQZU5RQlZVMWRzMC1pdQ?oc=5" target="_blank">Early Trial Data Show Promising Results for GM-CSF Blockade in CMML</a>  <font color="#6f6f6f">Hematology Advisor</font>

Virtually ouch-free: Promising early data on a measles vaccine delivered via sticker
NPRgeneral

Virtually ouch-free: Promising early data on a measles vaccine delivered via sticker

<a href="https://news.google.com/rss/articles/CBMi3AFBVV95cUxPNG8xVEJUQjlaSE5lcUJNbkhUSDl3Yk1aYkdLczVoTVp1eERQblZNclVYYzZXeVFVVHR2bWZLbHVIaEJxVVN2YklLTDhoVFFacnN2WXhvZnZtMG9kUFoxN20tWk95WWZJS2JwZG1Pdm85azIteXpvMXRnZzhwOG00TVFtU3RzSXVpLW5IX3dvUDJUZHk4Q0NCQlU0c3Z4TUNCRFNJbk9Ja0M5eFctUEQ2aWZkUEJzdElxYzVKUmVTUWNobDU0MmZSZmppZXN2NE9Ib2t3MjZDcnlnQlJX?oc=5" target="_blank">Virtually ouch-free: Promising early data on a measles vaccine delivered via sticker</a>  <font color="#6f6f6f">NPR</font>

Promising New Data on Stem Cell Therapy for Parkinson’s
Medscapegeneral

Promising New Data on Stem Cell Therapy for Parkinson’s

<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxNMzBoam10ckRxYjNYbVUzNjdsMjVTZjh2NFZvQm1lQVJLbHhGZ3BkSFU0M0Z6bFZsd2UwN0JuOTJ5czRjbUgtZXhjUUpQSXJXM2ZZdnIwZWQ2cm80MlBWV3RlaWNQckw3b1AxdWVlTnViZVNscjBfZGNmeVo2VWxLWUs1MGp6Ymg5WkV1MzZwWW5hUEtPeWo5NHhjWHhhdw?oc=5" target="_blank">Promising New Data on Stem Cell Therapy for Parkinson’s</a>  <font color="#6f6f6f">Medscape</font>

Kura Oncology Reports Promising Early Data for Darlifarnib in Combating Resistance in Targeted Cancer Therapies at ESMO 2025
Quiver Quantitativegeneral

Kura Oncology Reports Promising Early Data for Darlifarnib in Combating Resistance in Targeted Cancer Therapies at ESMO 2025

<a href="https://news.google.com/rss/articles/CBMi7gFBVV95cUxQTnY4VXNZbGFwa3djV3NlbldnTWRWWE1qNmxHdWtMcDZnT3RPc0k1MnBoY2NWa2hYeXgxRnVTaW5GS0EtWEl5T1VNbzlTNVd6ZTlVQzFxZVhpMFBWSTVSaEc0UDFEMHhxdExYSWNhUTVaTXJLZmMxNV9EUkU4ajNJZWRVQ2RJZUM1SUI4Z3VoYVlEVXhuRjJjNjRwZXJZWC1HWHZaUnVRT2pvRWI3UXRnclJIellCVGJ2Qk9kU0xZcWVjZVl3eXBWeHdwUzBxQkpXQjJReUJPMFBGckNVc1FlYTBQRTNQdVdibUlHOTFn?oc=5" target="_blank">Kura Oncology Reports Promising Early Data for Darlifarnib in Combating Resistance in Targeted Cancer Therapies at ESMO 2025</a>  <font color="#6f6f6f">Quiver Quantitative</font>

New Report Shows PAGA Reforms Already Delivering Promising Results for California Employers
CalChambergeneral

New Report Shows PAGA Reforms Already Delivering Promising Results for California Employers

<a href="https://news.google.com/rss/articles/CBMi0AFBVV95cUxNc25CMi02dVY1a2R4N2hxenVmWGJkdy1fbWNnRWhPNlFPRWltQjUxaFBDd0tvbExXT1BiTmQ3SnJjbE02dHlaeUttcjRDT0k2Y0pWQkpxdGUzZktpTFNkUmc5QlJZZmd2TW5IcDFiWVNRckN1eXNidDZHdkN6V0hENU1ESEI5YUxha2hzMFRmcFdlVk0ySmRPQlpxWW1XUzZUT0dkYWZXVlFOdGlRWm5sWmcyRGlfc05KU1Q0ekxqRk9NbW9nMDQ2SGloN0Z3LXRz?oc=5" target="_blank">New Report Shows PAGA Reforms Already Delivering Promising Results for California Employers</a>  <font color="#6f6f6f">CalChamber</font>

"Early Data Show Promising" — Live Google News Trends & Headlines